PT - JOURNAL ARTICLE AU - Toubiana, Laurent AU - Bouaud, Jacques TI - The estimated impact of the COVID-19 epidemic in the general population of France AID - 10.1101/2020.05.21.20106500 DP - 2020 Jan 01 TA - medRxiv PG - 2020.05.21.20106500 4099 - http://medrxiv.org/content/early/2020/05/26/2020.05.21.20106500.short 4100 - http://medrxiv.org/content/early/2020/05/26/2020.05.21.20106500.full AB - Background Model-based predictions for the COVID-19 outbreak revealed the potential for extraordinary mortality and saturation of health care systems if no action was taken. The pandemic hit France in late January 2020. Lockdown was implemented on March 17, 2020. The goal was to drastically reduce the number of infections, but at the cost of fear of a second epidemic wave when easing the lockdown. Our aim was to characterize the dynamics of the COVID-19 spread in France and estimate the proportion of coronavirus-infected individuals using ground truth from syndromic surveillance data.Methods National health authorities provide data from syndromic surveillance of the diagnosis of suspected COVID-19 reported by a sample of primary care physicians and from epidemic surveillance of confirmed cases, originating from hospitals. By extrapolation, COVID-19 incidence in the general population can be estimated. In turn, a back-calculation model can infer the number of contagious individuals, providing an idea of the spread of the epidemic before the implementation of lockdown measures.Results This study estimated that 12.3 million individuals were diagnosed ‘suspected COVID-19’ on May 6, 2020. At lockdown start, 2.5 million people were already contagious. The infection attack rate peaked on March 27, ten days after lockdown. The predicted sharp drop was not observed. The dynamics of the epidemic followed a continuous curve with a decline phase 2.35 times slower than the growth phase. 80% of infections occurred after lockdown.Conclusions These results call into question the effectiveness of lockdown. The epidemic would have followed its ‘natural trajectory’, beginning long before the health system detected the first cases. This hypothesis does not dispute the caution required with regard to the extraordinary spread of the epidemic, with less affected geographic areas becoming a source of susceptible individuals.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported directly by internal resources from the French National Institut for Health and Medical Research (INSERM) and Paris Public Hospitals (AP-HP) Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All relevant ethical guidelines have been followed; No necessary IRB and/or ethics committee approvals are required for this study.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesUsed data are publicly available. https://www.insee.fr/fr/statistiques/serie/ https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports/